Quote:COMPARE TRIAL and SITES - We can see that we were battling this other trial at atleast several sites and now many more will open up for us. It is very interesting. Check it out: - DaubersUP
CTIX:
Locations
United States, Florida
Recruiting
Lakeland, Florida, United States
United States, Missouri
Recruiting
St. Louis, Missouri, United States
United States, New York
Recruiting
Cheektowaga, New York, United States
Recruiting
Rochester, New York, United States
United States, Ohio
Recruiting
Cleveland, Ohio, United States
United States, Pennsylvania
Recruiting
Gettysburg, Pennsylvania, United States
Recruiting
Philadelphia, Pennsylvania, United States
United States, South Carolina
Recruiting
Charleston, South Carolina, United States
United States, South Dakota
Recruiting
Rapid City, South Dakota, United States
https://clinicaltrials.gov/ct2/show/NCT023243...amp;rank=3
Cobiprostone (Sucampo)
United States, Alabama
Investigational Site Recruiting
Birmingham, Alabama, United States, 35294
United States, Arizona
Investigational Site Recruiting
Peoria, Arizona, United States, 85381
Investigational Site Recruiting
Yuma, Arizona, United States, 85364
United States, Arkansas
Investigational Site Not yet recruiting
Little Rock, Arkansas, United States, 72205
United States, California
Investigational Site Recruiting
Duarte, California, United States, 91010
Investigational Site Recruiting
Fullerton, California, United States, 92835
Investigational Site Not yet recruiting
Los Angeles, California, United States, 90048
Investigational Site Recruiting
Montebello, California, United States, 90640
Investigational Site Recruiting
Oceanside, California, United States, 92056
Investigational Site Recruiting
Redondo Beach, California, United States, 90277
Investigational Site Not yet recruiting
San Francisco, California, United States, 94115
Investigational Site Not yet recruiting
Whittier, California, United States, 90603
United States, Colorado
Investigational Site Recruiting
Denver, Colorado, United States, 80210
United States, Connecticut
Investigational Site Not yet recruiting
Farmington, Connecticut, United States, 06030
United States, Florida
Investigational Site Not yet recruiting
Fort Lauderdale, Florida, United States, 33316
Investigational Site Recruiting
Fort Myers, Florida, United States, 33908
Investigational Site Withdrawn
Lake Worth, Florida, United States, 33461
Investigational Site Recruiting
Lakeland, Florida, United States, 33805
Investigational Site Not yet recruiting
Miami Beach, Florida, United States, 33140
Investigational Site Recruiting
Naples, Florida, United States, 34102
Investigational Site Recruiting
Plantation, Florida, United States, 33322
Investigational Site Recruiting
Stuart, Florida, United States, 34994
Investigational Site Recruiting
Winter Haven, Florida, United States, 33880
United States, Idaho
Investigational Site Not yet recruiting
Boise, Idaho, United States, 83706
United States, Illinois
Investigational Site Not yet recruiting
Urbana, Illinois, United States, 61801
United States, Indiana
Investigational Site Not yet recruiting
Fort Wayne, Indiana, United States, 46845
Investigational Site Recruiting
South Bend, Indiana, United States, 46601
United States, Kansas
Investigational Site Not yet recruiting
Topeka, Kansas, United States, 66606
United States, Kentucky
Investigational Site Recruiting
Ashland, Kentucky, United States, 41101
United States, Louisiana
Investigational Site Recruiting
Baton Rouge, Louisiana, United States, 70809
Investigational Site Not yet recruiting
Metairie, Louisiana, United States, 70006
Investigational Site Recruiting
New Orleans, Louisiana, United States, 70112
Investigational Site Recruiting
Shreveport, Louisiana, United States, 71103
United States, Maryland
Investigational Site Not yet recruiting
Baltimore, Maryland, United States, 21201
Investigational Site Not yet recruiting
Bethesda, Maryland, United States, 20889
United States, Massachusetts
Investigational Site Withdrawn
Boston, Massachusetts, United States, 02111
Investigational Site Recruiting
Burlington, Massachusetts, United States, 01805
United States, Michigan
Investigational Site Not yet recruiting
Ann Arbor, Michigan, United States, 48109
Investigational Site Recruiting
Detroit, Michigan, United States, 48201
Investigational Site Recruiting
East Lansing, Michigan, United States, 48867
United States, Minnesota
Investigational Site Recruiting
Minneapolis, Minnesota, United States, 55417
United States, Missouri
Investigational Site Recruiting
St. Louis, Missouri, United States, 63110
United States, Montana
Investigational Site Recruiting
Billings, Montana, United States, 59101
United States, Nebraska
Investigational Site Recruiting
Omaha, Nebraska, United States, 68198
United States, Nevada
Investigational Site Recruiting
Reno, Nevada, United States, 89502
United States, New Jersey
Investigational Site Recruiting
Egg Harbor Township, New Jersey, United States, 08234
Investigational Site Not yet recruiting
New Brunswick, New Jersey, United States, 08901
United States, New York
Investigational Site Withdrawn
Rochester, New York, United States, 14620
United States, North Carolina
Investigational Site Recruiting
Charlotte, North Carolina, United States, 28203
Investigational Site Recruiting
Gastonia, North Carolina, United States, 28054
Investigational Site Not yet recruiting
Greenville, North Carolina, United States, 27834
United States, Ohio
Investigational Site Not yet recruiting
Canton, Ohio, United States, 44718
Investigational Site Withdrawn
Cleveland, Ohio, United States, 44123
Investigational Site Recruiting
Sylvania, Ohio, United States, 43560
United States, Oklahoma
Investigational Site Recruiting
Oklahoma City, Oklahoma, United States, 73104
United States, Oregon
Investigational Site Recruiting
Coos Bay, Oregon, United States, 97420
Investigational Site Recruiting
Corvalis, Oregon, United States, 97330
Investigational Site Recruiting
Portland, Oregon, United States, 97227
United States, Pennsylvania
Investigational Site Recruiting
Gettysburg, Pennsylvania, United States, 17325
Investigational Site Recruiting
Hershey, Pennsylvania, United States, 17033
Investigational Site Recruiting
Natrona Heights, Pennsylvania, United States, 15065
Investigational Site Recruiting
Philadelphia, Pennsylvania, United States, 19104
Investigational Site Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Investigational Site Recruiting
State College, Pennsylvania, United States, 16801
United States, Rhode Island
Investigational Site Recruiting
Pawtucket, Rhode Island, United States, 02860
United States, South Carolina
Investigational Site Recruiting
Myrtle Beach, South Carolina, United States, 29577
United States, Tennessee
Investigational Site Recruiting
Cookeville, Tennessee, United States, 38501
United States, Texas
Investigational Site Not yet recruiting
Austin, Texas, United States, 78701
Investigational Site Recruiting
Fort Sam Houston, Texas, United States, 78234
Investigational Site Recruiting
Galveston, Texas, United States, 77555
Investigational Site Not yet recruiting
Houston, Texas, United States, 77030
Investigational Site Recruiting
Houston, Texas, United States, 77089
Investigational Site Recruiting
Temple, Texas, United States, 76508
United States, Virginia
Investigational Site Recruiting
Charlottesville, Virginia, United States, 22911
Investigational Site Recruiting
Fort Belvoir, Virginia, United States, 22060
United States, Washington
Investigational Site Recruiting
Bellingham, Washington, United States, 98225
Investigational Site Not yet recruiting
Everett, Washington, United States, 98201
Investigational Site Not yet recruiting
Seattle, Washington, United States, 98101
United States, West Virginia
Investigational Site Not yet recruiting
Morgantown, West Virginia, United States, 26506
United States, Wisconsin
Investigational Site Recruiting
Madison, Wisconsin, United States, 53792
https://clinicaltrials.gov/ct2/show/study/NCT...ocs=Y#locn
So we have 9 trial sites for B-OM and they had 80. And
Top 10 Most Recent News Articles
Ivonescimab Promises New Hope for Advanced BTC Patients
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue ReadingFirefox Champions Privacy with Iconic Internet Campaign
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue ReadingTop 5 Most Recently Viewed Articles
Phreesia Announces Q3 Fiscal Year 2025 Financial Results
Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...
Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience
Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...
Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead
Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...
Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025
Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....
Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19
New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...
Continue Reading